EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Variation in ABCB1, ADRB1, CYP3A4, CYP3A5, NEDD4L and NR3C2 Confers Differential Susceptibility to Resistant Hypertension among South Africans

Jonathan N Katsukunya iD, Erika Jones, Nyarai D Soko iD, Dirk Blom, Phumla Sinxadi, Brian Rayner iD, Collet Dandara iD

Journal of Personalized Medicine · 21.06.2024 · 14 (7) · 664

DOI: 10.3390/jpm14070664 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 21.06.2024. Verfasst von Jonathan N Katsukunya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, Univer…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistant hypertension (RHTN) prevalence ranges from 4 to 19% in Africa. There is a paucity of data on the role of genetic variation on RHTN among Africans. We set out to investigate the role of polymorphisms in ABCB1, ADRB1, CYP3A4, CYP3A5, NEDD4L, and NR3C2, on RHTN susceptibility among South Africans. Using a retrospective matched case–control study, 190 RHTN patients (cases: blood pressure (BP) ≥ 140/90 mmHg on ≥3 anti-hypertensives or BP < 140/90 mmHg on >3 anti-hypertensives) and 189 non-RHTN patients (controls:

Schlagwörter

Stichwörter der Autor:innen

Africansantihypertensive drugshypertensionpharmacogenomicsresistant hypertension

Autor:innen und Institutionen

  • Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town 7700, South Africa.
  • SAMRC/UCT Platform for Pharmacogenomics Research and Translation, South African Medical Research Council, Cape Town 7501, South Africa.
  • Department of Medicine, Division of Nephrology and Hypertension, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town 7700, South Africa.
  • Department of Pharmaceutical Technology, School of Allied Health Sciences, Harare Institute of Technology, Harare P.O. Box BE 277, Zimbabwe.
  • Department of Medicine, Division of Lipidology and Cape Heart Institute, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town 7700, South Africa.
  • Department of Medicine, Division of Clinical Pharmacology, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town 7700, South Africa.

ORCID-Profile: Jonathan N Katsukunya, Nyarai D Soko, Brian Rayner, Collet Dandara

Förderung

  • South African Medical Research Council

Zitieren

APA

Katsukunya, J. N., Jones, E., Soko, N. D., Blom, D., Sinxadi, P., Rayner, B., & Dandara, C. (2024). Genetic Variation in ABCB1, ADRB1, CYP3A4, CYP3A5, NEDD4L and NR3C2 Confers Differential Susceptibility to Resistant Hypertension among South Africans. Journal of Personalized Medicine, 14(7), 664. https://doi.org/10.3390/jpm14070664

Vancouver

Katsukunya JN, Jones E, Soko ND, Blom D, Sinxadi P, Rayner B, et al. Genetic Variation in ABCB1, ADRB1, CYP3A4, CYP3A5, NEDD4L and NR3C2 Confers Differential Susceptibility to Resistant Hypertension among South Africans. Journal of Personalized Medicine. 2024;14(7):664. doi:10.3390/jpm14070664

BibTeX
@article{Katsukunya2024,
  author = {Katsukunya, Jonathan N and Jones, Erika and Soko, Nyarai D and Blom, Dirk and Sinxadi, Phumla and Rayner, Brian and Dandara, Collet},
  title = {Genetic Variation in ABCB1, ADRB1, CYP3A4, CYP3A5, NEDD4L and NR3C2 Confers Differential Susceptibility to Resistant Hypertension among South Africans},
  journal = {Journal of Personalized Medicine},
  year = {2024},
  volume = {14},
  number = {7},
  pages = {664},
  doi = {10.3390/jpm14070664}
}
Kostenlos starten →